Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
- Authors:
- LaTonya J. Hickson
- Larissa G.P. Langhi Prata
- Shane A. Bobart
- Tamara K. Evans
- Nino Giorgadze
- Shahrukh K. Hashmi
- Sandra M. Herrmann
- Michael D. Jensen
- Qingyi Jia
- Kyra L. Jordan
- Todd A. Kellogg
- Sundeep Khosla
- Daniel M. Koerber
- Anthony B. Lagnado
- Donna K. Lawson
- Nathan K. LeBrasseur
- Lilach O. Lerman
- Kathleen M. McDonald
- James L. Kirkland
- Reference:
- eBioMedicine
- 2019
- 47
- 446-456
- DOI:
- 10.1016/j.ebiom.2019.08.069